| [1] |
WANG Haochen, JIA Liqing, YANG Yu, WANG Qian, YU Chengli, TIAN Tian, BI Rui, TU Xiaoyu, BAI Qianming, ZHU Xiaoli, ZHOU Xiaoyan, REN Min.
A study on the correlation between HPV DNA and IHC P16 expression in cervical lesions
[J]. China Oncology, 2025, 35(3): 298-308.
|
| [2] |
SHEN Jie, LIU Wanlin, WANG Zezhou, MU Sibo, MO Miao, ZHOU Changming, YUAN Jing, WANG Yu, ZHENG Ying, JI Qinghai.
Survival and cause-of-death analysis of 55 thousand thyroid cancer cases in China from a large single institution hospital-based cancer registry database
[J]. China Oncology, 2025, 35(1): 68-76.
|
| [3] |
ZHOU Xueqin, LUAN Yanchao, ZHAO Li, RONG Chaochao, YANG Na.
Expression of CDC20 in lung adenocarcinoma tissues and its effect on the proliferation and invasion of lung adenocarcinoma cells
[J]. China Oncology, 2024, 34(5): 460-472.
|
| [4] |
MA Fenghua, JIANG Anqi, CHEN Yiqing, XU Congjian, KANG Yu.
Magnetic resonance imaging for distinguishing gastric-type endocervical adenocarcinoma from lobular endocervical glandular hyperplasia
[J]. China Oncology, 2024, 34(4): 380-388.
|
| [5] |
SHEN Jie, WANG Jiangli, WANG Zezhou, MO Miao, ZHOU Changming, YUAN Jing, XU Dazhi, ZHENG Ying.
Survival analysis of 6 737 surgically resected gastric cancer cases in China from a large single institution hospital-based cancer registry database
[J]. China Oncology, 2024, 34(3): 268-277.
|
| [6] |
XU Ziqi, HU Ruizhi, LI Junjian, WANG Hongxia, SANG Youzhou.
Exploring the role of methylation-driven gene IFFO1 in pancreatic adenocarcinoma diagnosis, prognosis and cellular functions
[J]. China Oncology, 2024, 34(11): 998-1010.
|
| [7] |
LIU Wei, XIE Tiansong, CHEN Lei, ZHANG Zehua, ZHOU Zhengrong.
Investigating the value of dual-layer spectral detector CT in distinguishing resectable pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis
[J]. China Oncology, 2024, 34(1): 67-73.
|
| [8] |
JIA Liqing, GE Xiaolu, JIANG Lin, ZHOU Xiaoyan.
Effects of lncRNA PKD2-2-3 on cell proliferation, clone formation, migration, and invasion of lung adenocarcinoma
[J]. China Oncology, 2023, 33(8): 717-725.
|
| [9] |
DONG Hao, QIU Yonggang, WANG Xinbin, YANG Junjie, LOU Cuncheng, YIN Lekang, YE Xiaodan.
Predictive value of logistic regression model based on high-resolution CT signs for high-grade pattern in stage ⅠA lung adenocarcinoma
[J]. China Oncology, 2023, 33(8): 768-775.
|
| [10] |
LIU Xiaoli, CHAI Wenjun, SUN Lei, YAN Mingxia, PAN Hongyu, SUN Yuexi.
Analysis of differential splicing gene by regulation of splicing regulatory protein KHSRP in lung adenocarcinoma
[J]. China Oncology, 2023, 33(7): 637-645.
|
| [11] |
HONG Yaping, HUANG Yunjian, HUANG Zhangzhou, CHEN Shengjia, ZHONG Qiaofeng, ZENG Hongfu, ZHUANG Wu.
Efficacy and prognostic predictors of first-generation EGFR TKI-targeted therapy in patients with EGFR-mutated advanced non-small cell lung cancer
[J]. China Oncology, 2022, 32(7): 624-634.
|
| [12] |
MU Jiaqian, TENG Xiaoyan, WEI Lirong, QIU Rong, GUI Pengcheng, DU Yuzhen.
The role and application value of integrin β3 in bone metastasis of lung adenocarcinoma
[J]. China Oncology, 2022, 32(4): 351-356.
|
| [13] |
ZHU Haipeng, HU Jun, JIANG Min, CAI Ruonan, WANG Junqiao, LI Li.
A study on mechanism of GOLM1 regulating PI3K/AKT/mTOR signaling pathway to promote proliferation, invasion and migration of lung adenocarcinoma cells
[J]. China Oncology, 2022, 32(3): 207-217.
|
| [14] |
WANG Zimao, CAO Yuan, WANG Qiying.
Construction and validation of the survival prediction model for patients with cutaneous spindle cell melanoma
[J]. China Oncology, 2022, 32(3): 234-242.
|
| [15] |
HOU Qinghua, ZHONG Yanfeng, LIU Linzhuang, WU Liusheng, LIU Jixian.
Expression, prognostic value of CBX3 in lung adenocarcinoma and its effect on biological behavior of cancer cells
[J]. China Oncology, 2022, 32(2): 152-160.
|